Supplementation With Conjugated Linoleic Acid (CLA) as Complementary Therapy in the Management of Type 2 Diabetes Mellitus (Women's Diabetes Study) (WDS)
This study has been completed.
Study NCT01121471
Information provided by Ohio State University
First Received on May 10, 2010.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
